A detailed history of Fmr LLC transactions in Vericel Corp stock. As of the latest transaction made, Fmr LLC holds 2,372,812 shares of VCEL stock, worth $132 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,372,812
Previous 2,350,351 0.96%
Holding current value
$132 Million
Previous $108 Million 7.03%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.25 - $53.56 $948,977 - $1.2 Million
22,461 Added 0.96%
2,372,812 $100 Million
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $10.1 Million - $12.8 Million
241,765 Added 11.47%
2,350,351 $108 Million
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $49.3 Million - $79.4 Million
1,517,519 Added 256.74%
2,108,586 $110 Million
Q4 2023

Feb 13, 2024

BUY
$30.85 - $37.09 $609,873 - $733,232
19,769 Added 3.46%
591,067 $21 Million
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $5.12 Million - $6.34 Million
161,652 Added 39.46%
571,298 $19.1 Million
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $147,929 - $195,725
5,101 Added 1.26%
409,646 $15.4 Million
Q1 2023

May 11, 2023

BUY
$23.85 - $31.34 $627,732 - $824,868
26,320 Added 6.96%
404,545 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $101,840 - $157,924
5,770 Added 1.55%
378,225 $9.96 Million
Q3 2022

Nov 10, 2022

SELL
$22.62 - $32.54 $30,333 - $43,636
-1,341 Reduced 0.36%
372,455 $8.64 Million
Q2 2022

Aug 12, 2022

BUY
$22.88 - $39.45 $95,203 - $164,151
4,161 Added 1.13%
373,796 $9.41 Million
Q1 2022

May 13, 2022

BUY
$31.69 - $43.29 $466,730 - $637,575
14,728 Added 4.15%
369,635 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$35.2 - $52.6 $101,516 - $151,698
-2,884 Reduced 0.81%
354,907 $13.9 Million
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $115,040 - $148,299
2,482 Added 0.7%
357,791 $17.5 Million
Q2 2021

Aug 13, 2021

BUY
$47.2 - $67.81 $16.8 Million - $24.1 Million
355,309 New
355,309 $18.7 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.62B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.